drugset / Trial / NCT01265641

To Investigate the Effects of AZD1981 on the QT Interval

NCT01265641

Phase 1 Completed 44 enrolled AstraZeneca
RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of this research study is to evaluate the effect of AZD1981 on the electrical activity of the heart, in particular when the heart muscle is relaxed during a heart beat cycle. The effect of AZD1981 will be compared to a licensed antibiotic (moxifloxacin) which is well known to affect the electrical activity of the heart, but this effect is known to be at levels that are safe at the dose used in this study. The investigators will also compare the effects of AZD1981 with a "dummy drug" (placebo). The investigators will also be evaluating how safe and well tolerated AZD1981 is and how much AZD1981 enters the blood circulation by collecting blood during the study.

Timeline

Start
2011-01
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1981 Small molecule 200 mg Oral
Subject AZD1981 Small molecule 2000 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral

Indications